Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glutamate Receptor”

50 trials

Showing 20 of 50 results

Testing effectiveness (Phase 2)UnknownNCT03651557
What this trial is testing

Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients

Who this might be right for
Cardiac Arrest
GNT Pharma 150
Early research (Phase 1)Ended earlyNCT01420952
What this trial is testing

Imaging of Brain Receptors Using (11C)mGlu1

Who this might be right for
DosimetryPharmacokinetics
National Institute of Mental Health (NIMH) 3
Testing effectiveness (Phase 2)Study completedNCT00001930
What this trial is testing

Treatment of Huntington's Chorea With Amantadine

Who this might be right for
ChoreaHuntington's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 25
Not applicableUnknownNCT00317668
What this trial is testing

Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients

Who this might be right for
Epilepsy
Hadassah Medical Organization 250
Early research (Phase 1)Study completedNCT01548703
What this trial is testing

A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers

Who this might be right for
Healthy
BrainCells Inc. 30
Post-approval studies (Phase 4)Study completedNCT01108029
What this trial is testing

Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease

Who this might be right for
Parkinson's DiseaseGait Disorders, Neurologic
University Hospital, Lille 28
Not applicableStudy completedNCT02236897
What this trial is testing

PET Imaging in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Johns Hopkins University 36
Early research (Phase 1)Study completedNCT00538798
What this trial is testing

PET Imaging of Brain mGluR5 Receptors Using [18F]SP203

Who this might be right for
HealthyGlutamate ReceptormGlur5 Protein+3 more
National Institute of Mental Health (NIMH) 50
Testing effectiveness (Phase 2)Study completedNCT01882829
What this trial is testing

Nuedexta in Treatment-Resistant Major Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant
James Murrough 20
Early research (Phase 1)Study completedNCT01896843
What this trial is testing

Evaluation of Two Radioactive Chemicals to Image mGluR5 Receptors in Brain

Who this might be right for
mGluR5 Receptors
National Institute of Mental Health (NIMH) 19
Testing effectiveness (Phase 2)Study completedNCT00004576
What this trial is testing

Study of LY300164 for the Treatment of Parkinson's Disease

Who this might be right for
DyskinesiasParkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 20
Not applicableStudy completedNCT00042523
What this trial is testing

Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 61
Testing effectiveness (Phase 2)Study completedNCT01482221
What this trial is testing

Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca 542
Early research (Phase 1)Study completedNCT02286817
What this trial is testing

Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder

Who this might be right for
Attention-deficit Hyperactivity Disorder (ADHD)
Aevi Genomic Medicine, LLC, a Cerecor company 30
Post-approval studies (Phase 4)WithdrawnNCT02028026
What this trial is testing

The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives

Who this might be right for
Major Depressive DisorderAnxietyComorbidity
Massachusetts General Hospital
Not applicableStudy completedNCT04350567
What this trial is testing

Sleep/Wake Cycle and Depression: An Imaging and Treatment Study

Who this might be right for
Depression; Major Depressive Disorder
Stony Brook University 61
Not applicableStudy completedNCT00980408
What this trial is testing

The Influence of Glutamate on Memory in Humans

Who this might be right for
Healthy Individuals
University Hospital, Bonn 120
Early research (Phase 1)Study completedNCT02769936
What this trial is testing

Glutamate, Learning, and Working Memory

Who this might be right for
Schizophrenia
University of California, Los Angeles 110
Not applicableStudy completedNCT02456168
What this trial is testing

Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Northwell Health 30
Testing effectiveness (Phase 2)Study completedNCT00001929
What this trial is testing

Treatment of Parkinson's Disease With Eliprodil

Who this might be right for
Movement DisordersParkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 20
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation